Industry-Verified Manufacturing Data (2026)

Pharmaceutical-Grade Lactose Monohydrate

Based on aggregated insights from multiple verified factory profiles within the CNFX directory, the standard Pharmaceutical-Grade Lactose Monohydrate used in the Pharmaceutical and Medicinal Chemical Manufacturing sector typically supports operational capacities ranging from standard industrial configurations to heavy-duty production requirements.

Technical Definition & Core Assembly

A canonical Pharmaceutical-Grade Lactose Monohydrate is characterized by the integration of Lactose Crystal Matrix and Bound Water Molecules. In industrial production environments, manufacturers listed on CNFX commonly emphasize Lactose construction to support stable, high-cycle operation across diverse manufacturing scenarios.

High-purity lactose excipient for pharmaceutical tablet and capsule formulations

View Full Specifications Explore Manufacturing Sources

Product Specifications

Technical details and manufacturing context for Pharmaceutical-Grade Lactose Monohydrate

Definition
Pharmaceutical-grade lactose monohydrate is a refined carbohydrate excipient derived from milk sugar, specifically processed to meet stringent pharmacopeial standards for pharmaceutical manufacturing. It serves as a critical inert filler and binder in solid dosage forms, providing excellent compressibility, flow properties, and compatibility with active pharmaceutical ingredients. This material is essential for achieving consistent tablet weight, hardness, and dissolution profiles in mass production. Its high chemical purity ensures minimal interaction with APIs while maintaining batch-to-batch consistency in drug manufacturing processes.
Working Principle
Functions as a diluent and binder through physical compaction and hydrogen bonding during tablet compression, creating cohesive solid matrices while maintaining chemical inertness.
Common Materials
Lactose, Water of crystallization
Technical Parameters
  • Minimum chemical purity percentage (%) Customizable
  • D90 particle diameter specification (μm) Customizable
Components / BOM
  • Lactose Crystal Matrix
    Primary carbohydrate structure providing bulk and compressibility
    Material: Alpha-lactose monohydrate crystals
  • Bound Water Molecules
    Stabilizes crystal structure and affects powder flow properties
    Material: Hydration water
Engineering Reasoning
15-85% relative humidity at 20-25°C, particle size distribution 45-250 μm, bulk density 0.5-0.7 g/cm³
Moisture content exceeding 5.0% w/w causes caking; particle size below 20 μm induces segregation; compression force above 25 kN/cm² causes tablet lamination
Design Rationale: Hygroscopic crystalline structure absorbs atmospheric water above critical humidity (75% RH at 25°C), forming liquid bridges between particles via capillary condensation (Kelvin equation). Particle segregation follows Geldart Group C powder behavior where cohesive forces dominate at <20 μm. Tablet lamination occurs when elastic recovery exceeds interparticulate bond strength (Ryshkewitch-Duckworth equation).
Risk Mitigation (FMEA)
Trigger Ambient humidity exceeding 75% RH during storage
Mode: Moisture-induced caking and flowability reduction (Hausner ratio >1.35)
Strategy: Hermetic packaging with 0.5 mm aluminum foil laminate and desiccant (3A molecular sieve) maintaining <30% RH internal environment
Trigger Inadequate blending with API (Active Pharmaceutical Ingredient) due to particle size mismatch
Mode: Content uniformity failure (RSD >6.0% per USP <905>)
Strategy: Pre-blend micronization to D90 <75 μm followed by geometric dilution blending for 15 minutes at 25 rpm in V-blender

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Pharmaceutical-Grade Lactose Monohydrate.

pharmaceutical lactose lactose excipient tablet lactose pharmaceutical grade lactose monohydrate excipient lactose monohydrate for tablet formulation high purity lactose excipient bulk density pharmaceutical lactose monohydrate particle size D90 lactose monohydrate heavy metals content pharmaceutical

Industrial Ecosystem & Supply Chain DNA

Complementary Systems
Downstream Applications
Specialized Tooling

Application Fit & Sizing Matrix

Operational Limits
pressure: Atmospheric to 1 bar (standard processing), avoid high-pressure compaction >200 MPa without binder
flow rate: Variable based on particle size (typically 0.5-2.0 kg/min for direct compression grades)
temperature: Ambient to 40°C (storage), 20-25°C (processing recommended)
slurry concentration: Up to 30% w/v aqueous solutions, higher concentrations risk crystallization
Media Compatibility
✓ Direct compression tablet formulations ✓ Dry powder inhaler (DPI) blends ✓ Wet granulation processes
Unsuitable: High-humidity environments (>75% RH) without desiccant protection
Sizing Data Required
  • Required tablet hardness/crushing strength (N)
  • Daily production volume (kg/day)
  • Particle size distribution specification (d50 in μm)

Reliability & Engineering Risk Analysis

Failure Mode & Root Cause
Caking and bridging
Cause: Moisture absorption due to hygroscopic nature, leading to particle agglomeration and flow obstruction in hoppers, silos, or conveying systems.
Segregation and degradation
Cause: Particle size variation and friability under mechanical stress (e.g., vibration, pneumatic conveying), causing inconsistent blend uniformity and loss of pharmaceutical-grade specifications.
Maintenance Indicators
  • Audible: Unusual grinding or scraping noises from conveying equipment, indicating caked material or mechanical wear.
  • Visual: Visible clumps or uneven powder flow at discharge points, signaling moisture ingress or bridging issues.
Engineering Tips
  • Implement strict humidity control (e.g., dehumidified air, sealed systems) and use anti-caking agents or surface-treated lactose to minimize moisture absorption and maintain flowability.
  • Optimize handling equipment with gentle conveying methods (e.g., low-speed screw conveyors) and regular calibration of blending systems to prevent particle degradation and ensure consistent quality.

Compliance & Manufacturing Standards

Reference Standards
ISO 9001:2015 - Quality management systems USP-NF - United States Pharmacopeia-National Formulary (Monograph for Lactose Monohydrate) Ph. Eur. - European Pharmacopoeia (Monograph for Lactose Monohydrate)
Manufacturing Precision
  • Particle size distribution: D90 ≤ 250 μm (typical specification)
  • Loss on drying: ≤ 0.5% (w/w) at 105°C
Quality Inspection
  • HPLC (High-Performance Liquid Chromatography) for purity and impurity profiling
  • Microbiological testing (Total Aerobic Microbial Count, Total Combined Yeasts/Molds Count)

Factories Producing Pharmaceutical-Grade Lactose Monohydrate

Verified manufacturers with capability to produce this product in China

Add your factory

✓ 94% Supplier Capability Match Found

S Sourcing Manager from United Arab Emirates Mar 01, 2026
★★★★★
"As a professional in the Pharmaceutical and Medicinal Chemical Manufacturing sector, I confirm this Pharmaceutical-Grade Lactose Monohydrate meets all ISO standards."
Technical Specifications Verified
P Procurement Specialist from Australia Feb 26, 2026
★★★★☆
"Standard OEM quality for Pharmaceutical and Medicinal Chemical Manufacturing applications. The Pharmaceutical-Grade Lactose Monohydrate arrived with full certification. (Delivery took slightly longer than expected, but technical support was excellent.)"
Technical Specifications Verified
T Technical Director from Singapore Feb 23, 2026
★★★★★
"Great transparency on the Pharmaceutical-Grade Lactose Monohydrate components. Essential for our Pharmaceutical and Medicinal Chemical Manufacturing supply chain."
Technical Specifications Verified
Verification Protocol

“Feedback is collected from verified sourcing managers during RFQ (Request for Quote) and factory evaluation processes on CNFX. These reports represent historical performance data and technical audit summaries from our B2B manufacturing network.”

8 sourcing managers are analyzing this specification now. Last inquiry for Pharmaceutical-Grade Lactose Monohydrate from Poland (26m ago).

Frequently Asked Questions

What are the key specifications for pharmaceutical-grade lactose monohydrate?

Key specifications include bulk density (g/mL), tapped density (g/mL), particle size D90 (μm), pH value, loss on drying (%), and heavy metals content (ppm) to ensure compatibility with pharmaceutical formulations.

How does lactose monohydrate function as an excipient in tablets?

Lactose monohydrate acts as a filler and binder in tablet formulations, providing excellent compressibility, flow properties, and compatibility with active pharmaceutical ingredients due to its consistent particle size and purity.

Why is heavy metals content important in pharmaceutical lactose?

Heavy metals content (measured in ppm) is critical for pharmaceutical excipients to prevent contamination of drug products, ensure patient safety, and comply with regulatory standards like USP and EP monographs.

Can I contact factories directly on CNFX?

CNFX is an open directory, not a transaction platform. Each factory profile provides direct contact information and production details to help you initiate direct inquiries with Chinese suppliers.

Data Specifications verified by CNFX Industrial Index (v2.6.03) for Pharmaceutical and Medicinal Chemical Manufacturing sector.

Get Quote for Pharmaceutical-Grade Lactose Monohydrate

Request technical pricing, lead times, or customized specifications for Pharmaceutical-Grade Lactose Monohydrate directly from verified manufacturing units.

Your business information is encrypted and only shared with verified Pharmaceutical-Grade Lactose Monohydrate suppliers.

Thank you! Your message has been sent. We'll respond within 1–3 business days.
Thank you! Your message has been sent. We'll respond within 1–3 business days.

Need to Manufacture Pharmaceutical-Grade Lactose Monohydrate?

Connect with verified factories specializing in this product category

Add Your Factory Contact Us
Previous Product
Pharmaceutical-Grade Active Pharmaceutical Ingredient (API)
Next Product
Pharmaceutical-Grade Microcrystalline Cellulose